GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast AS (OTCPK:CLPBY) » Definitions » Equity-to-Asset

CLPBY (Coloplast AS) Equity-to-Asset : 0.32 (As of Dec. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Coloplast AS Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Coloplast AS's Total Stockholders Equity for the quarter that ended in Dec. 2024 was $2,171 Mil. Coloplast AS's Total Assets for the quarter that ended in Dec. 2024 was $6,787 Mil. Therefore, Coloplast AS's Equity to Asset Ratio for the quarter that ended in Dec. 2024 was 0.32.

The historical rank and industry rank for Coloplast AS's Equity-to-Asset or its related term are showing as below:

CLPBY' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.17   Med: 0.41   Max: 0.61
Current: 0.32

During the past 13 years, the highest Equity to Asset Ratio of Coloplast AS was 0.61. The lowest was 0.17. And the median was 0.41.

CLPBY's Equity-to-Asset is ranked worse than
82.11% of 872 companies
in the Medical Devices & Instruments industry
Industry Median: 0.64 vs CLPBY: 0.32

Coloplast AS Equity-to-Asset Historical Data

The historical data trend for Coloplast AS's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast AS Equity-to-Asset Chart

Coloplast AS Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.55 0.52 0.22 0.36 0.37

Coloplast AS Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.31 0.34 0.34 0.37 0.32

Competitive Comparison of Coloplast AS's Equity-to-Asset

For the Medical Instruments & Supplies subindustry, Coloplast AS's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Coloplast AS's Equity-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Coloplast AS's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Coloplast AS's Equity-to-Asset falls into.



Coloplast AS Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Coloplast AS's Equity to Asset Ratio for the fiscal year that ended in Sep. 2024 is calculated as

Equity to Asset (A: Sep. 2024 )=Total Stockholders Equity/Total Assets
=2670.735/7155.85
=0.37

Coloplast AS's Equity to Asset Ratio for the quarter that ended in Dec. 2024 is calculated as

Equity to Asset (Q: Dec. 2024 )=Total Stockholders Equity/Total Assets
=2170.848/6787.043
=0.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Coloplast AS  (OTCPK:CLPBY) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Coloplast AS Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Coloplast AS's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Coloplast AS Business Description

Address
Holtedam 1-3, Humlebaek, DNK, DK-3050
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast AS Headlines

From GuruFocus

Coloplast A/S Annual Shareholders Meeting Transcript

By GuruFocus Research 02-13-2024

Q2 2022 Coloplast A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q4 2023 Coloplast A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q2 2024 Coloplast A/S Earnings Call Transcript

By GuruFocus Research 05-08-2024

Q3 2024 Coloplast A/S Earnings Call Transcript

By GuruFocus Research 08-21-2024

Coloplast A/S Meet the Management Event Transcript

By GuruFocus Research 02-13-2024

Q3 2021 Coloplast A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Coloplast A/S Virtual ESG Event Call Transcript

By GuruFocus Research 02-13-2024

Q1 2022 Coloplast A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024